APA (7th ed.) Citation

KL, O., T, G., P, F., CS, C., & A, M. (2022). Protection from COVID-19 with a VSV-based vaccine expressing the spike and nucleocapsid proteins. Frontiers in immunology, 13, 1025500. https://doi.org/10.3389/fimmu.2022.1025500

Chicago Style (17th ed.) Citation

KL, O'Donnell, Gourdine T, Fletcher P, Clancy CS, and Marzi A. "Protection from COVID-19 with a VSV-based Vaccine Expressing the Spike and Nucleocapsid Proteins." Frontiers in Immunology 13 (2022): 1025500. https://doi.org/10.3389/fimmu.2022.1025500.

MLA (9th ed.) Citation

KL, O'Donnell, et al. "Protection from COVID-19 with a VSV-based Vaccine Expressing the Spike and Nucleocapsid Proteins." Frontiers in Immunology, vol. 13, 2022, p. 1025500, https://doi.org/10.3389/fimmu.2022.1025500.